• FirefoxInstall the new Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.27%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    70.30 Down 0.40(0.57%) Mar 26, 4:00PM EDT
    Add to Portfolio
    Prev Close:70.70
    Open:70.82
    Bid:60.03 x 200
    Ask:N/A
    1y Target Est:89.40
    Beta:1.4
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:67.16 - 71.67
    52wk Range:41.99 - 79.61
    Volume:515,865
    Avg Vol (3m):338,121
    Market Cap:1.38B
    P/E (ttm):125.54
    EPS (ttm):0.56
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    LGNDDown 0.57%1.38B
    LLYDown 1.24%77.89B
    MRKDown 1.13%163.48B
    RHHBYDown 1.61%N/A

    Key Statistics

    Forward P/E (1 yr):21.24
    P/S (ttm):21.45
    Ex-Dividend Date:02-Jul-10

    Analysts

    Annual EPS Est (Dec-15) :2.17
    Quarterly EPS Est (Mar-15) :0.27
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):0.76

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ligand Pharmaceuticals Incorporated operates as a biotechnology company in the United States. The company’s commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis that is used for ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback